Non-Invasive Brain-Computer Interface Startup Mailian Medical Secures $14 Million to Expand At-Home Neuro-Rehabilitation

Zhejiang Mailian Medical Technology Co., Ltd. announced it has completed a 100 million yuan ($14.1 million) Series B funding round, fueling the commercial expansion of its non-invasive brain-computer interface (BCI) technologies across clinical and home rehabilitation environments. The investment round was jointly led by Chuangda Industry Control and GSR United Capital. Founded in 2018, the Hangzhou-based medical technology company specializes in non-invasive BCI platforms for the diagnosis, closed-loop treatment, and long-term management of neurological conditions and emotional disorders. Mailian Medical is developing a multidisciplinary ecosystem combining non-invasive neural monitoring with generative artificial intelligence. Its current product lineup includes sleep cognition…